Synthesis of characteristic lipopeptides of the human N-Ras protein and their evaluation as possible inhibitors of protein farnesyl transferase

被引:29
作者
Stober, P [1 ]
Schelhaas, M [1 ]
Nagele, E [1 ]
Hagenbuch, P [1 ]
Retey, J [1 ]
Waldmann, H [1 ]
机构
[1] UNIV KARLSRUHE,INST ORGAN CHEM,D-76128 KARLSRUHE,GERMANY
关键词
D O I
10.1016/S0968-0896(96)00213-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipopeptides carrying a farnesyl thioether or a palmitic acid thioester and a farnesyl thioether were prepared from S-farnesyl cysteine methyl ester by N-terminal extension of the peptide chain employing the base labile Fmoc blocking group or the palladium(0) sensitive Aloc urethane. By means of this technique a lipohexapeptide representing the completely functionalized, i.e. palmitoylated and farnesylated C-terminus of the human N-Ras protein, was prepared. If acid labile blocking functions like the Boc group were used, upon deprotection an undesired addition of the acid to the double bonds of the farnesyl residue occurred. Therefore, acid labile blocking groups should not be employed in the synthesis of farnesylated lipopeptides. The lipopeptide methyl esters which carry only a farnesyl group do not inhibit protein farnesyl transferase, whereas palmitoylated peptides are weak inhibitors of this enzyme. Copyright (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:75 / 83
页数:9
相关论文
共 36 条
[11]   PURIFIED YEAST PROTEIN FARNESYLTRANSFERASE IS STRUCTURALLY AND FUNCTIONALLY SIMILAR TO ITS MAMMALIAN COUNTERPART [J].
GOMEZ, R ;
GOODMAN, LE ;
TRIPATHY, SK ;
OROURKE, E ;
MANNE, V ;
TAMANOI, F .
BIOCHEMICAL JOURNAL, 1993, 289 :25-31
[12]   A BIOCHEMICAL FUNCTION FOR RAS - AT LAST [J].
HALL, A .
SCIENCE, 1994, 264 (5164) :1413-1414
[13]   ALL RAS PROTEINS ARE POLYISOPRENYLATED BUT ONLY SOME ARE PALMITOYLATED [J].
HANCOCK, JF ;
MAGEE, AI ;
CHILDS, JE ;
MARSHALL, CJ .
CELL, 1989, 57 (07) :1167-1177
[14]   Potent, cell active, non-thiol tetrapeptide inhibitors of farnesyltransferase [J].
Hunt, JT ;
Lee, VG ;
Leftheris, K ;
Seizinger, B ;
Carboni, J ;
Mabus, J ;
Ricca, C ;
Yan, N ;
Manne, V .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (02) :353-358
[15]   PROTEIN FARNESYLTRANSFERASE INHIBITORS BLOCK THE GROWTH OF RAS-DEPENDENT TUMORS IN NUDE-MICE [J].
KOHL, NE ;
WILSON, FR ;
MOSSER, SD ;
GIULIANI, E ;
DESOLMS, SJ ;
CONNER, MW ;
ANTHONY, NJ ;
HOLTZ, WJ ;
GOMEZ, RP ;
LEE, TJ ;
SMITH, RL ;
GRAHAM, SL ;
HARTMAN, GD ;
GIBBS, JB ;
OLIFF, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (19) :9141-9145
[16]   INHIBITION OF FARNESYLTRANSFERASE INDUCES REGRESSION OF MAMMARY AND SALIVARY CARCINOMAS IN RAS TRANSGENIC MICE [J].
KOHL, NE ;
OMER, CA ;
CONNER, MW ;
ANTHONY, NJ ;
DAVIDE, JP ;
DESOLMS, SJ ;
GIULIANI, EA ;
GOMEZ, RP ;
GRAHAM, SL ;
HAMILTON, K ;
HANDT, LK ;
HARTMAN, GD ;
KOBLAN, KS ;
KRAL, AM ;
MILLER, PJ ;
MOSSER, SD ;
ONEILL, TJ ;
RANDS, E ;
SCHABER, MD ;
GIBBS, JB ;
OLIFF, A .
NATURE MEDICINE, 1995, 1 (08) :792-797
[17]   THE ALLYLOXYCARBONYL (ALOC) MOIETY - CONVERSION OF AN UNSUITABLE INTO A VALUABLE AMINO PROTECTING GROUP FOR PEPTIDE-SYNTHESIS [J].
KUNZ, H ;
UNVERZAGT, C .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH, 1984, 23 (06) :436-437
[18]  
Kunz H., 1984, ANGEW CHEM, V96, P426
[19]   Development of highly potent inhibitors of Ras farnesyltransferase possessing cellular and in vivo activity [J].
Leftheris, K ;
Kline, T ;
Vite, GD ;
Cho, YH ;
Bhide, RS ;
Patel, DV ;
Patel, MM ;
Schmidt, RJ ;
Weller, HN ;
Andahazy, ML ;
Carboni, JM ;
GulloBrown, JL ;
Lee, FYF ;
Ricca, C ;
Rose, WC ;
Yan, N ;
Barbacid, M ;
Hunt, JT ;
Meyers, CA ;
Seizinger, BR ;
Zahler, R ;
Manne, V .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (01) :224-236
[20]   SIGNAL-TRANSDUCTION THERAPY - A NOVEL-APPROACH TO DISEASE MANAGEMENT [J].
LEVITZKI, A .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 226 (01) :1-13